Global In-Vitro Transcription Templates Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

 In-vitro transcription templates are DNA sequences designed to serve as the blueprint for RNA synthesis in a controlled laboratory setting. These templates contain specific promoter regions recognized by RNA polymerase, facilitating the production of RNA molecules for various applications, including research, diagnostic development, and therapeutic production. They providie a precise and reliable source for RNA generation, along with molecular biology and genetic research.


Sizing and Forecast
The in-vitro transcription templates market size has grown exponentially in recent years. It will grow from $0.82 billion in 2023 to $1.01 billion in 2024 at a compound annual growth rate (CAGR) of 23.4%. The growth in the historic period can be attributed to rise in cases of chronic diseases, increase in investments in R&D in healthcare and pharmaceutical sectors, improvements in gene therapy technology, collaborations and partnerships and developments in gene therapy.

The in-vitro transcription templates market size is expected to see exponential growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%. The growth in the forecast period can be attributed to Increase in advancement in biotechnology, rise in focus in R&D activities, rise in usage of in-vitro transcription templates, demand for early diagnosis of diseases and increasing need for mRNA-based vaccines. Major trends in the forecast period include developments in RNA synthesis technologies, technological advancements, advancement in biotechnology, advancements in enzymatic synthesis techniques, and integration of automation and digitalization.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/in-vitro-transcription-templates-global-market-report

Segmentation & Regional Insights
The in-vitro transcription templates market covered in this report is segmented –
1) By Treatment: Vaccine, Therapeutic
2) By Research Stage:  Exploratory, Clinical
3) By Disease: Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academics And Research, Other End Users

North America was the largest region in the in-vitro transcription templates market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro transcription templates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15838&type=smp


Major Driver Impacting Market Growth
The increasing focus on gene therapy is expected to propel the growth of the in-vitro transcription templates market. Gene therapy involves modifying genes within cells to treat or prevent diseases by correcting defective genes. Advances in technologies such as CRISPR, significant investment, and recent treatment successes have increased focus on this approach. In-vitro transcription templates help in gene therapy by providing the RNA molecules necessary for mRNA-based therapies, siRNA-based therapies, and gene editing technologies, enabling the treatment of genetic disorders and diseases. For instance, in March 2024, the Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services, estimated that 36 gene therapies were approved by the FDA, with an additional 500 in the pipeline and the expectation that 10-20 will be approved annually by 2025. Therefore, the increasing focus on gene therapy is driving the growth of the in-vitro transcription templates market.

Key Industry Players
Major companies operating in the in-vitro transcription templates market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Cayman Chemical, Synthego Corporation, Synbio Technologies, Creative Diagnostics, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia

The in-vitro transcription templates market report table of contents includes:
1. Executive Summary

2. In-Vitro Transcription Templates Market Characteristics

3. In-Vitro Transcription Templates Market Trends And Strategies

4. In-Vitro Transcription Templates Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global In-Vitro Transcription Templates Market Size and Growth

.
32. Global In-Vitro Transcription Templates Market Competitive Benchmarking

33. Global In-Vitro Transcription Templates Market Competitive Dashboard

34. Key Mergers And Acquisitions In The In-Vitro Transcription Templates Market

35. In-Vitro Transcription Templates Market Future Outlook and Potential Analysis

35.1 In-Vitro Transcription Templates Market In 2028 - Countries Offering Most New Opportunities

35.2 In-Vitro Transcription Templates Market In 2028 - Segments Offering Most New Opportunities

35.3 In-Vitro Transcription Templates Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Post a Comment

Popular posts from this blog

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Generative Artificial Intelligence (AI) In Telecom Market Industry Outlook Presents Revenue And CAGR Projections To 2030

Image
  The generative artificial intelligence (AI) in telecom market size has grown exponentially in recent years. It will grow from $0.73 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 53.4%. The growth in the historic period can be attributed to growing mobile subscriber base, increasing telecom data traffic, early adoption of AI in network management, rising demand for personalized customer experiences, expansion of cloud-based telecom solutions. The generative artificial intelligence (AI) in telecom market size is expected to see exponential growth in the next few years. It will grow to $6.16 billion in 2030 at a compound annual growth rate (CAGR) of 53.0%. The growth in the forecast period can be attributed to advancements in generative AI models, integration of AI with 5G and future networks, growth in edge computing for real-time analytics, adoption of AI for security and fraud prevention, expansion of AI-driven customer support solutions. M...
Read more